South African pharmaceutical group Aspen Pharmacare has acquired Nestle’s infant milk factory in Mexico and licences for some of its brands in Latin America.

The latest deal between Aspen and Nestle will see the South African group gain licence rights to intellectual property, a production facility in Vallejo in Mexico, and shares in the businesses conducted by Nestlé and Pfizer in Latin America, Aspen said.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The transaction follows a similar deal in April that saw Aspen buy licences for some of Nestle’s infant milk brands in southern Africa and Australia for A$215m.

The agreement includes the exclusive right of use of the Nestlé S26 Gold and SMA trademarks for ten years in South and Central America. It will also have the right to co-brand the licensed products over the same period.

The revenue for the infant nutrition businesses totalled US$187m in 2012.

Australian competition authorities have approved the acquisition, while South African and Namibian approval is pending, Aspen said.